Saturday, July 11, 2026
In Detail Full day, Saturday, July 11, 2026, Timezone: America/Chicago
OpenEvidence launches medical AI copilot feature that grades medical evidence and unveils NewYork-Presbyterian collaboration
fiercehealthcare - OpenEvidence developed a medical AI copilot feature that provides a real-time assessment of the strength of the evidence behind each applicable answer.
AI Summary: OpenEvidence has unveiled an AI copilot that grades medical evidence and offers decision support, accompanied by a deployment partnership with NewYork‑Presbyterian. The tool aims to speed evidence appraisal and standardize recommendations across a large health network, promising efficiency gains — or at least fewer literature‑review headaches for clinicians.
A $1B Acquisition Gives Novartis a Way to Stand Out in Crowded Area of Cancer
Frank Vinluan / medcitynews - Myricx Bio brings to Novartis antibody drug conjugates with a novel cancer-killing payload called an NMT inhibitor. Novartis says Myricx’s drugs could have advantages over currently available ADCs as well as those still in clinical development. The post A…
AI Summary: Novartis has struck a roughly $1 billion deal to acquire Myricx Bio, a preclinical bet aimed at securing a novel antibody‑drug conjugate payload. The move is a clear attempt to stand out in a crowded oncology market by buying potential innovation rather than inventing it in‑house — or, as finance folks call it, buying optionality.
Two tests GPs can soon offer to help spot endometriosis
bbc - Experts hope they will be a game-changer and cut the nine-year or longer diagnosis waits patients can currently face.
AI Summary: Emerging research on hormonal signatures and blood biomarkers has led to development of tests GPs may soon use to spot endometriosis earlier. Patient accounts underline the life‑changing potential of timely diagnosis. The work promises less guesswork, fewer invasive procedures, and fewer years lost to unexplained pain—so yes, medicine might actually make life convenient for once.
- GP tests and NHS rollout to shorten diagnosis (3)
- Hormone and symptom research reveals diagnostic signatures (3)
- Work, wellbeing and cost pressures on patients (3)
GP tests and NHS rollout to shorten diagnosis
Hormone and symptom research reveals diagnostic signatures
Work, wellbeing and cost pressures on patients
Gene clues reveal why some rare leukemia patients resist tagraxofusp therapy
medicalxpress - Researchers at The University of Texas MD Anderson Cancer Center have identified why some patients with a rare type of leukemia, called blastic plasmacytoid dendritic cell neoplasm (BPDCN), eventually develop resistance to tagraxofusp, the first Food and …
AI Summary: Researchers have identified decreased TXNRD1 and related molecular changes that appear linked to resistance against tagraxofusp in BPDCN patients. This insight exposes a plausible resistance mechanism and opens opportunities to test predictive biomarkers or combination strategies to overcome failure, which is welcome news for clinicians facing a stubborn, high‑risk disease.
First-in-human immunotherapy more than doubles progression-free survival in glioblastoma patients
medicalxpress - Glioblastoma, the most aggressive malignant brain tumor in adults, remains one of the most challenging cancers to treat because of limited treatment options and a poor prognosis. Patient outcomes have remained largely unchanged in the past two decades, un…
AI Summary: A first‑in‑human immunotherapy study in recurrent glioblastoma reported a more than twofold improvement in progression‑free survival, drawing attention to anti‑LAG‑3 strategies with or without anti‑PD‑1. While early and limited, the results provide a rare hint of efficacy in a notoriously treatment‑resistant cancer and warrant expedited follow‑up.
Meningococcal B vaccine ineffective in gonorrhea prevention for men who have sex with men
medicalxpress - The meningococcal B vaccine is ineffective in gonorrhea prevention among men who have sex with men (MSM) at high risk of infection, according to findings from the world's largest randomized controlled trial (RCT) into possible efficacy published in the Ne…
AI Summary: A major study found that the meningococcal B (MenB) vaccine does not provide protection against gonorrhea in men who have sex with men, contradicting earlier hopes that cross-protection might exist. Researchers emphasize the need for dedicated gonorrhea vaccines and continued public-health measures to control rising infection rates.
IKS Health completes $557M TruBridge acquisition
Andrew Cass / beckershospitalreview - IKS Health has completed its $557 million acquisition of TruBridge, which provides revenue cycle management and EHR services for rural and community hospitals. Following the closing, TruBridge operates as a wholly owned subsidiary of IKS Health, according…
AI Summary: IKS Health has closed a $557 million deal to acquire TruBridge, integrating the acquired firm’s revenue-cycle and IT capabilities into IKS’s technology stack. The purchase accelerates IKS’s push to expand managed services for health systems, promising greater scale and product consolidation—because nothing says progress like buying your way into the future.
Feds push back HIPAA security rule overhaul to July 2027
fiercehealthcare - The 125-page proposed update prompted fierce pushback from hospitals, health systems and other healthcare stakeholders who warned it would place substantial financial burdens on organizations.
AI Summary: Federal regulators have postponed the overhaul of the HIPAA Security Rule, moving implementation to July 2027 to give covered entities and business associates more time to prepare for tightened cybersecurity and compliance requirements. The delay aims to ease operational pressure while agencies finalize technical details and enforcement timelines—yes, more paperwork, but with slightly more breathing room.
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Olfaction, FDA, Vaccine Safety, Infectious Disease and look for the RSS link.
StackHealth Time Machine
More StackHealth